Discovery & Development

The Drugs for Neglected Diseases initiative has a new leader – and he’s on a mission to redefine global health for an egalitarian, postcolonial world

AMR remains a pressing issue, but hydroquinine has yielded some interesting effects on clinically important bacteria

Insights into the quest to find an effective treatment for this socially painful condition

Is now finally the time for Alzheimer’s drug development to shine?

In 2014, the Ice Bucket Challenge raised millions; eight years on, we have an FDA-approved therapy

Pharma must ask itself how it will contribute to the fight against women’s mental health challenges.

Researchers examine how changes in the gut – including those that result from posture – affect drug bioavailability.

How global collaborations are inching us toward a victory over a neglected parasitic disease

Keith Horspool reflects on the efforts that led the FDA to launch its pilot review program for novel excipients

Can AI usher in a new age of medicine or is it all hype? In this blog, we go down the rabbit hole.